US panel endorses WHO's antimalarial artesunate suppository for young children
This article was originally published in Scrip
Executive Summary
The US FDA's external experts overwhelmingly endorsed the World Health Organization's NDA for artesunate rectal suppositories for young children with malaria, but recommended against licensing a higher dose for older children and adults.